QT Imaging Holdings, Inc.
NASDAQ:QTI · NASDAQ Global Market
+$0.10 today
Vol 0.06M · Avg 0.05M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
-327.1%
avg -58.0%
ROIC
-28.4%
avg -43.5%
ROA
-91.6%
avg -73.0%
Analysis
ROIC is currently the strongest return metric at -28.4% versus its period average of -43.5%. 0 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Raluca Dinu | Chief Executive Officer & Director | $635,894.00 | — | 53 | $908,845.00 | 3.35% |
Jay W. Jennings | Chief Financial Officer | $344,384.00 | — | 59 | $2,800.00 | 0.01% |
Satrajit Misra | Chief Commercial Officer | — | — | — | — | — |
Nasser C. Pirshafiey | Chief Product Officer | — | — | — | — | — |
Steve Choate | Chief Operating Officer | — | — | — | — | — |
Elaine Iuanow | Chief Medical Officer | — | — | — | — | — |
Bilal Malik | Chief Science Officer | — | — | — | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A1 analysts |
| Revenue | N/A | N/A | N/A | +58.5% (3yr)1 analysts |
| Net Income | N/A | N/A | N/A | N/A1 analysts |
| EBIT | N/A | N/A | N/A | N/A1 analysts |
Analysis
Forward estimates point to Revenue at +58.5% (3yr), giving you a quick read on expected growth from here.
Competitors
Peer companies in the same sector
Korro Bio, Inc.
NASDAQ:KRRO
$127.20M
Synaptogenix, Inc.
SNPX
$10.91M
Cyclacel Pharmaceuticals, Inc.
CYCC
$10.61M
Agile Therapeutics, Inc.
AGRX
$10.43M
China Jo-Jo Drugstores, Inc.
CJJD
$9.95M
Field Trip Health Ltd.
FTRP
$9.81M
NeuroMetrix, Inc.
NURO
$9.43M
ProSomnus, Inc.
OSA
$8.18M
Nexalin Technology, Inc.
NXL
$8.03M
Scorpius Holdings, Inc.
SCPX
$13,626.00
Who manages QTI?
QT Imaging Holdings, Inc. (QTI) lists 7 active executives. The top listed executive is Satrajit Misra, Chief Commercial Officer.
Are QTI insiders buying or selling?
Recent insider activity shows net buying of $32.09M.
Explore More
Continue the stock analysis
Jump to another research area for this company.